QT
EIDX

Quantbot Technologies’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Quantbot Technologies’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200
Closed -$26K – 1909
2020
Q4 		$26K Buy
+200
New +$17.7K ﹤0.01% 977
2020
Q1 		– Sell
-3,724
Closed -$213K – 1587
2019
Q4 		$213K Buy
3,724
+1,132
+44% +$56K 0.02% 645
2019
Q3 		$93K Buy
+2,592
New +$101K 0.01% 851

Quantbot Technologies's EIDX Position: Q1 2021 in Review

Quantbot Technologies sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 200 shares — an estimated $26K sold.

Quantbot Technologies first reported a position in EIDX in Q3 2019 and held it in 3 quarters. The position peaked at $213K in Q4 2019. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • Quantbot Technologies reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Quantbot Technologies sold 200 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $26K.
  • Quantbot Technologies first reported a position in Eidos Therapeutics, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
  • Quantbot Technologies's Eidos Therapeutics, Inc. Common Stock position peaked at $213K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Quantbot Technologies's 13F filing for Q1 2021, filed 14 May 2021.